| VRTX | Vertex Pharmaceuticals Inc | $121.26B | +1976101.50% |
| VRNA | Verona Pharma Plc | $77.75B | +1267003.22% |
| REGN | Regeneron Pharmaceuticals Inc | $69.10B | +1126116.03% |
| ARGX | Argen X SE | $57.12B | +930879.11% |
| ALNY | Alnylam Pharmaceuticals Inc | $36.95B | +602123.07% |
| RVMD | Revolution Medicines Inc | $36.92B | +601626.14% |
| ONC | BeiGene Ltd | $36.03B | +587187.02% |
| MRNA | Moderna Inc | $27.11B | +441684.10% |
| ROIV | Roivant Sciences Ltd | $25.13B | +409511.39% |
| RPRX | Royalty Pharma plc - Class A | $24.60B | +400752.20% |
| INSM | Insmed Inc | $23.78B | +387398.17% |
| BNTX | BioNTech SE | $23.26B | +379030.29% |
| INCY | Incyte Corp | $23.01B | +374943.45% |
| GMAB | Genmab | $18.57B | +302534.36% |
| ASND | Ascendis Pharma A/S | $17.33B | +282317.12% |
| BBIO | BridgeBio Pharma Inc | $16.18B | +263550.97% |
| JAZZ | Jazz Pharmaceuticals plc | $14.81B | +241332.48% |
| EXEL | Exelixis Inc | $14.09B | +229584.82% |
| MDGL | Madrigal Pharmaceuticals Inc | $12.68B | +206535.41% |
| AXSM | Axsome Therapeutics Inc | $12.21B | +198958.33% |
| SMMT | Summit Therapeutics Inc | $11.69B | +190494.70% |
| BMRN | Biomarin Pharmaceutical Inc | $11.39B | +185582.84% |
| TECH | Bio-Techne Corp | $11.19B | +182234.81% |
| ABVX | Abivax | $10.86B | +176862.53% |
| KRYS | Krystal Biotech Inc | $10.31B | +167929.43% |
| CYTK | Cytokinetics Inc | $10.18B | +165888.96% |
| ARWR | Arrowhead Pharmaceuticals Inc | $10.10B | +164438.37% |
| APGE | Apogee Therapeutics Inc | $10.06B | +163788.87% |
| NUVL | Nuvalent Inc - Class A | $9.75B | +158834.74% |
| KYMR | Kymera Therapeutics Inc | $9.38B | +152749.87% |
| CORT | Corcept Therapeutics Inc | $9.35B | +152352.55% |
| IONS | Ionis Pharmaceuticals Inc | $9.08B | +147880.09% |
| HALO | Halozyme Therapeutics Inc | $8.99B | +146357.79% |
| PRAX | Praxis Precision Medicines Inc | $8.87B | +144477.24% |
| CRNX | Crinetics Pharmaceuticals Inc | $8.84B | +143903.86% |
| PTGX | Protagonist Therapeutics Inc | $8.70B | +141693.12% |
| TGTX | TG Therapeutics Inc | $8.64B | +140647.27% |
| PCVX | Vaxcyte Inc | $8.19B | +133352.53% |
| IMVT | Immunovant Inc | $8.13B | +132451.42% |
| IBRX | ImmunityBio Inc | $8.10B | +131845.24% |
| SYRE | Spyre Therapeutics Inc | $8.05B | +131050.52% |
| RYTM | Rhythm Pharmaceuticals Inc | $7.51B | +122258.84% |
| MTSR | Metsera Inc | $7.40B | +120578.61% |
| MIRM | Mirum Pharmaceuticals Inc | $7.37B | +120047.65% |
| MRUS | Merus N.V | $6.83B | +111142.90% |
| COGT | Cogent Biosciences Inc | $6.71B | +109280.49% |
| ACLX | Arcellx Inc | $6.67B | +108539.22% |
| XENE | Xenon Pharmaceuticals Inc | $6.54B | +106526.32% |
| PTCT | PTC Therapeutics Inc | $6.53B | +106395.93% |
| CDTX | Cidara Therapeutics Inc | $6.49B | +105741.60% |
| SRRK | Scholar Rock Holding Corp | $6.44B | +104797.93% |
| CGON | Cg Oncology Inc | $6.42B | +104605.60% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | +102029.85% |
| TERN | Terns Pharmaceuticals Inc | $5.95B | +96832.01% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $5.93B | +96607.10% |
| BLTE | Belite Bio Inc | $5.88B | +95732.76% |
| ERAS | Erasca Inc | $5.51B | +89642.61% |
| DNTH | Dianthus Therapeutics Inc | $5.45B | +88777.21% |
| APLS | Apellis Pharmaceuticals Inc | $5.25B | +85441.37% |
| TVTX | Travere Therapeutics Inc | $5.24B | +85348.60% |
| CRSP | CRISPR Therapeutics AG | $4.95B | +80595.14% |
| CAI | Caris Life Sciences Inc - Class A | $4.94B | +80330.43% |
| FOLD | Amicus Therapeutics Inc | $4.50B | +73309.26% |
| ACAD | Acadia Pharmaceuticals Inc | $4.43B | +72172.99% |
| CELC | Celcuity Inc | $4.42B | +72005.38% |
| EWTX | Edgewise Therapeutics Inc | $4.39B | +71421.93% |
| VKTX | Viking Therapeutics Inc | $4.38B | +71315.66% |
| AKRO | Akero Therapeutics Inc | $4.38B | +71286.41% |
| TNGX | Tango Therapeutics Inc | $4.36B | +70972.87% |
| ORKA | ARCA biopharma Inc | $4.35B | +70746.46% |
| LEGN | Legend Biotech Corp | $4.26B | +69267.05% |
| DYN | Dyne Therapeutics Inc | $3.96B | +64490.68% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | +62605.19% |
| TLX | Telix Pharmaceuticals Ltd | $3.82B | +62235.46% |
| NAMS | NewAmsterdam Pharma Company NV | $3.73B | +60693.65% |
| RLAY | Relay Therapeutics Inc | $3.69B | +60062.54% |
| DNLI | Denali Therapeutics Inc | $3.65B | +59423.54% |
| ALMS | Alumis Inc | $3.60B | +58615.84% |
| GPCR | Structure Therapeutics Inc | $3.53B | +57373.16% |
| RCUS | Arcus Biosciences Inc | $3.52B | +57210.99% |
| ARQT | Arcutis Biotherapeutics Inc | $3.47B | +56512.74% |
| ELVN | Enliven Therapeutics Inc | $3.24B | +52653.90% |
| IDYA | Ideaya Biosciences Inc | $3.23B | +52506.26% |
| BEAM | Beam Therapeutics Inc | $3.17B | +51540.19% |
| RARE | Ultragenyx Pharmaceutical Inc | $3.12B | +50701.42% |
| VERA | Vera Therapeutics Inc - Class A | $3.04B | +49408.39% |
| IRON | Disc Medicine Inc | $2.90B | +47216.09% |
| MBX | MBX Biosciences Inc | $2.89B | +46940.64% |
| SLNO | Soleno Therapeutics Inc | $2.74B | +44581.41% |
| KOD | Kodiak Sciences Inc | $2.64B | +42871.21% |
| IMNM | Immunome Inc | $2.59B | +42174.39% |
| QURE | uniQure N.V. | $2.58B | +42019.15% |
| CLDX | Celldex Therapeutics Inc | $2.55B | +41463.30% |
| TARS | Tarsus Pharmaceuticals Inc | $2.47B | +40216.01% |
| NRIX | Nurix Therapeutics Inc | $2.47B | +40208.77% |
| MLYS | Mineralys Therapeutics Inc | $2.43B | +39532.69% |
| VCEL | Vericel Corp | $2.38B | +38740.45% |
| AGIO | Agios Pharmaceuticals Inc | $2.37B | +38459.34% |
| MESO | Mesoblast Ltd | $2.36B | +38308.71% |
| ETNB | 89bio Inc | $2.34B | +38084.55% |
| TRVI | Trevi Therapeutics Inc | $2.33B | +37873.92% |
| SLS | SELLAS Life Sciences Group Inc | $2.32B | +37698.31% |
| PHVS | Pharvaris NV | $2.30B | +37321.67% |
| ZLAB | Zai Lab Ltd | $2.27B | +36884.60% |
| BHVN | Biohaven Ltd | $2.24B | +36374.74% |
| DAWN | Day One Biopharmaceuticals Inc | $2.22B | +36035.52% |
| OCUL | Ocular Therapeutix Inc | $2.18B | +35432.44% |
| AUPH | Aurinia Pharmaceuticals Inc | $2.11B | +34213.37% |
| SNDX | Syndax Pharmaceuticals Inc | $2.08B | +33840.79% |
| IOVA | Iovance Biotherapeutics Inc | $2.08B | +33744.19% |
| ABCL | AbCellera Biologics Inc | $2.05B | +33287.34% |
| NUVB | Nuvation Bio Inc - Class A | $2.04B | +33218.54% |
| HRMY | Harmony Biosciences Holdings Inc | $2.02B | +32814.36% |
| ADMA | Adma Biologics Inc | $2.02B | +32760.52% |
| SION | Sionna Therapeutics Inc | $2.00B | +32502.83% |
| GLUE | Monte Rosa Therapeutics Inc | $1.97B | +32071.17% |
| ATAI | ATAI Life Sciences N.V. | $1.96B | +31833.98% |
| VRDN | Viridian Therapeutics Inc | $1.95B | +31726.97% |
| URGN | UroGen Pharma Ltd | $1.94B | +31494.53% |
| TYRA | Tyra Biosciences Inc | $1.93B | +31283.30% |
| NBTX | Nanobiotix | $1.91B | +31042.80% |
| RAPP | Rapport Therapeutics Inc | $1.91B | +31011.50% |
| GLPG | Galapagos NV | $1.90B | +30837.37% |
| AAPG | Ascentage Pharma Group International | $1.87B | +30355.96% |
| STOK | Stoke Therapeutics Inc | $1.86B | +30239.92% |
| SRPT | Sarepta Therapeutics Inc | $1.86B | +30199.16% |
| BCAX | Bicara Therapeutics Inc | $1.84B | +29934.28% |
| ZBIO | Zenas Biopharma Inc | $1.83B | +29801.29% |
| PGEN | Precigen Inc | $1.82B | +29598.11% |
| ZYME | Zymeworks BC Inc | $1.80B | +29280.05% |
| TSHA | Taysha Gene Therapies Inc | $1.78B | +28881.27% |
| IMCR | Immunocore Holdings plc | $1.76B | +28630.40% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $1.76B | +28524.95% |
| FTRE | Fortrea Holdings Inc | $1.69B | +27512.95% |
| NKTR | Nektar Therapeutics | $1.69B | +27434.51% |
| MPLT | MapLight Therapeutics Inc | $1.69B | +27404.78% |
| GHRS | GH Research PLC | $1.67B | +27116.43% |
| ANAB | AnaptysBio Inc | $1.62B | +26310.38% |
| INVA | Innoviva Inc | $1.62B | +26231.48% |
| NTLA | Intellia Therapeutics Inc | $1.57B | +25497.73% |
| RAPT | RAPT Therapeutics Inc | $1.56B | +25396.10% |
| VIR | Vir Biotechnology Inc | $1.55B | +25152.61% |
| SEPN | Septerna Inc | $1.53B | +24840.48% |
| AVBP | ArriVent BioPharma Inc | $1.49B | +24231.30% |
| ABSI | Absci Corp | $1.49B | +24230.95% |
| MAZE | Maze Therapeutics Inc | $1.46B | +23723.78% |
| MLTX | MoonLake Immunotherapeutics - Class A | $1.42B | +23085.45% |
| NVAX | Novavax Inc | $1.39B | +22489.94% |
| KALV | KalVista Pharmaceuticals Inc | $1.38B | +22446.43% |
| INBX | Inhibrx Biosciences Inc | $1.33B | +21616.29% |
| ARDX | Ardelyx Inc | $1.31B | +21233.01% |
| IMTX | Immatics N.V | $1.28B | +20680.98% |
| MNKD | Mannkind Corp | $1.26B | +20491.01% |
| ANNX | Annexon Inc | $1.26B | +20472.58% |
| CRVS | Corvus Pharmaceuticals Inc | $1.25B | +20347.56% |
| TRML | Tourmaline Bio Inc | $1.24B | +20039.46% |
| SVRA | Savara Inc | $1.19B | +19303.99% |
| CAPR | Capricor Therapeutics Inc | $1.17B | +19024.95% |
| EYPT | EyePoint Pharmaceuticals Inc | $1.16B | +18737.26% |
| ORIC | ORIC Pharmaceuticals Inc | $1.15B | +18688.61% |
| WVE | Wave Life Sciences Ltd | $1.14B | +18425.83% |
| XNCR | Xencor Inc | $1.11B | +17981.94% |
| DRTS | Alpha Tau Medical Ltd | $1.10B | +17772.07% |
| CGEM | Cullinan Oncology Inc | $1.10B | +17757.02% |
| JBIO | Jade Biosciences Inc | $1.08B | +17480.36% |
| CVAC | CureVac N.V. | $1.05B | +17001.26% |
| OLMA | Olema Pharmaceuticals Inc | $1.03B | +16723.71% |
| MGTX | MeiraGTx Holdings plc | $1.02B | +16571.94% |
| KURA | Kura Oncology Inc | $1.01B | +16290.34% |
| VTYX | Ventyx Biosciences Inc | $998.72M | +16176.79% |
| GRCL | Gracell Biotechnologies Inc | $989.87M | +16032.55% |
| VOR | Vor Biopharma Inc | $979.68M | +15866.44% |
| JANX | Janux Therapeutics Inc | $975.67M | +15801.22% |
| ANRO | Alto Neuroscience Inc | $973.06M | +15758.69% |
| SANA | Sana Biotechnology Inc | $957.85M | +15510.75% |
| GERN | Geron Corp | $950.51M | +15391.16% |
| SLDB | Solid Biosciences Inc | $946.56M | +15326.70% |
| PHAR | Pharming Group N.V. | $939.88M | +15217.90% |
| LXRX | Lexicon Pharmaceuticals Inc | $936.56M | +15163.74% |
| DBVT | DBV Technologies | $930.17M | +15059.55% |
| LBRX | LB Pharmaceuticals Inc | $922.18M | +14929.44% |
| ABUS | Arbutus Biopharma Corp | $898.08M | +14536.66% |
| PHAT | Phathom Pharmaceuticals Inc | $877.84M | +14206.73% |
| TBPH | Theravance Biopharma Inc | $872.15M | +14114.01% |
| DSGN | Design Therapeutics Inc | $844.21M | +13658.64% |
| REPL | Replimune Group Inc | $800.70M | +12949.56% |
| ACRS | Aclaris Therapeutics Inc | $782.06M | +12645.71% |
| OCS | Oculis Holding AG | $772.84M | +12495.46% |
| ZVRA | Zevra Therapeutics Inc | $766.13M | +12386.12% |
| CMRX | Chimerix Inc | $766.03M | +12384.52% |
| RIGL | Rigel Pharmaceuticals | $758.21M | +12257.01% |
| SPRY | ARS Pharmaceuticals Inc | $749.72M | +12118.64% |
| OMER | Omeros Corporation | $746.63M | +12068.28% |
| MNPR | Monopar Therapeutics Inc | $728.12M | +11766.69% |
| DRUG | Bright Minds Biosciences Inc | $728.06M | +11765.71% |
| ATXS | Astria Therapeutics Inc | $709.95M | +11470.56% |
| CADL | Candel Therapeutics Inc | $706.21M | +11409.52% |
| XOMA | XOMA Royalty Corp | $699.64M | +11302.53% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $673.55M | +10877.28% |
| CLYM | Eliem Therapeutics Inc | $662.55M | +10698.03% |
| CRMD | CorMedix Inc | $660.09M | +10657.92% |
| IVA | Inventiva | $655.21M | +10578.48% |
| CTMX | CytomX Therapeutics Inc | $652.36M | +10532.04% |
| RLMD | Relmada Therapeutics Inc | $651.37M | +10515.80% |
| MDXG | Mimedx Group Inc | $635.94M | +10264.30% |
| RGNX | Regenxbio Inc | $633.34M | +10221.99% |
| PRME | Prime Medicine Inc | $630.35M | +10173.22% |
| NGNE | Neoleukin Therapeutics Inc | $616.04M | +9940.07% |
| TECX | AvroBio Inc | $611.99M | +9874.01% |
| FDMT | 4D Molecular Therapeutics Inc | $610.53M | +9850.28% |
| GYRE | Gyre Therapeutics Inc | $599.17M | +9665.11% |
| IMMX | Immix Biopharma Inc | $558.22M | +8997.65% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $555.56M | +8954.41% |
| CTNM | Contineum Therapeutics Inc - Class A | $546.27M | +8802.94% |
| ARVN | Arvinas Inc | $534.06M | +8603.94% |
| NVCT | Nuvectis Pharma Inc | $519.64M | +8368.85% |
| STTK | Shattuck Labs Inc | $511.69M | +8239.34% |
| ZURA | Zura Bio Ltd - Class A | $511.41M | +8234.75% |
| VSTM | Verastem Inc | $503.34M | +8103.29% |
| SLN | Silence Therapeutics Plc | $493.60M | +7944.57% |
| OCGN | Ocugen Inc | $483.80M | +7784.76% |
| KYTX | Kyverna Therapeutics Inc | $470.94M | +7575.28% |
| ALLO | Allogene Therapeutics Inc | $465.15M | +7480.89% |
| SVA | Sinovac Biotech Ltd | $464.94M | +7477.43% |
| CABA | Cabaletta Bio Inc | $463.15M | +7448.28% |
| RZLT | Rezolute Inc | $456.43M | +7338.68% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $451.41M | +7256.96% |
| EVMN | Evommune Inc | $447.71M | +7196.61% |
| PRTA | Prothena Corporation plc | $447.44M | +7192.25% |
| BNTC | Benitec Biopharma Inc | $447.29M | +7189.85% |
| VALN | Valneva SE | $440.98M | +7086.93% |
| CBIO | N/A | $432.05M | +6941.45% |
| STRO | Sutro Biopharma Inc | $430.74M | +6920.02% |
| AURA | Aura Biosciences Inc | $430.49M | +6915.98% |
| PBYI | Puma Biotechnology Inc | $427.89M | +6873.69% |
| ASMB | Assembly Biosciences Inc | $424.80M | +6823.30% |
| OVID | Ovid Therapeutics Inc | $416.49M | +6687.88% |
| ABEO | Abeona Therapeutics Inc | $414.56M | +6656.30% |
| DMAC | DiaMedica Therapeutics Inc | $411.67M | +6609.25% |
| CYBN | Cybin Inc | $408.43M | +6556.50% |
| AVTX | Avalo Therapeutics Inc | $403.76M | +6480.41% |
| AUTL | Autolus Therapeutics plc | $401.88M | +6449.66% |
| RCKT | Rocket Pharmaceuticals Inc | $398.30M | +6391.39% |
| LRMR | Larimar Therapeutics Inc | $395.79M | +6350.53% |
| UPB | Upstream Bio Inc | $395.63M | +6347.91% |
| CCCC | C4 Therapeutics Inc | $395.34M | +6343.10% |
| IPSC | Century Therapeutics Inc | $390.82M | +6269.50% |
| YMAB | Y-Mabs Therapeutics Inc | $390.19M | +6259.17% |
| AVIR | Atea Pharmaceuticals Inc | $388.93M | +6238.69% |
| CMPX | Compass Therapeutics Inc | $385.39M | +6180.94% |
| ENTA | Enanta Pharmaceuticals Inc | $384.48M | +6166.09% |
| RVNC | Revance Therapeutics Inc | $380.38M | +6099.27% |
| PRTC | PureTech Health plc American Depositary Shares | $376.98M | +6043.96% |
| ALT | Altimmune Inc | $373.67M | +5990.04% |
| TENX | Tenax Therapeutics Inc | $372.39M | +5969.03% |
| PRLD | Prelude Therapeutics Inc | $368.04M | +5898.19% |
| XFOR | X4 Pharmaceuticals Inc | $367.85M | +5895.05% |
| FENC | Fennec Pharmaceuticals Inc | $366.13M | +5867.15% |
| VNDA | Vanda Pharmaceuticals Inc | $351.79M | +5633.37% |
| LXEO | Lexeo Therapeutics Inc | $351.17M | +5623.28% |
| EDIT | Editas Medicine Inc | $349.39M | +5594.17% |
| FATE | Fate Therapeutics Inc | $347.65M | +5565.97% |
| FBRX | Forte Biosciences Inc | $340.15M | +5443.69% |
| ZNTL | Zentalis Pharmaceuticals Inc | $340.13M | +5443.27% |
| PALI | Palisade Bio Inc | $339.87M | +5439.03% |
| IMAB | I-Mab | $339.64M | +5435.28% |
| EPRX | Eupraxia Pharmaceuticals Inc | $338.64M | +5419.11% |
| IMRX | Immuneering Corp Class A | $333.64M | +5337.55% |
| LYEL | Lyell Immunopharma Inc | $332.66M | +5321.64% |
| FHTX | Foghorn Therapeutics Inc | $319.97M | +5114.81% |
| INDP | Indaptus Therapeutics Inc | $319.34M | +5104.56% |
| ANL | Adlai Nortye Ltd | $317.46M | +5073.79% |
| GALT | Galectin Therapeutics Inc | $313.48M | +5008.98% |
| LCTX | Lineage Cell Therapeutics Inc | $305.39M | +4877.16% |
| VTVT | vTv Therapeutics Inc - Class A | $305.06M | +4871.77% |
| ELDN | Eledon Pharmaceuticals Inc | $304.92M | +4869.56% |
| SCPH | scPharmaceuticals Inc | $304.59M | +4864.12% |
| ARTV | Artiva Biotherapeutics Inc | $302.86M | +4835.95% |
| OABI | OmniAb Inc | $301.15M | +4808.05% |
| BCYC | Bicycle Therapeutics Plc | $294.16M | +4694.19% |
| NMRA | Neumora Therapeutics Inc | $293.19M | +4678.34% |
| GLSI | Greenwich LifeSciences Inc | $286.57M | +4570.49% |
| TTRX | Turn Therapeutics Inc | $285.37M | +4550.86% |
| CLLS | Cellectis | $282.48M | +4503.80% |
| TRDA | Entrada Therapeutics Inc | $276.01M | +4398.40% |
| NAGE | Niagen Bioscience Inc | $275.72M | +4393.53% |
| MGNX | Macrogenics Inc | $274.58M | +4375.01% |
| SABS | SAB Biotherapeutics Inc | $274.20M | +4368.75% |
| ALXO | Alx Oncology Holdings Inc | $273.12M | +4351.19% |
| IKT | Inhibikase Therapeutics Inc | $271.99M | +4332.76% |
| SRZN | Surrozen Inc | $250.37M | +3980.41% |
| IRD | Ocuphire Pharma Inc | $248.48M | +3949.66% |
| RNAC | Cartesian Therapeutics Inc | $247.77M | +3938.05% |
| THRD | Third Harmonic Bio Inc | $241.86M | +3841.83% |
| FULC | Fulcrum Therapeutics Inc | $237.12M | +3764.59% |
| GNFT | GENFIT S.A. American Depositary Shares | $233.01M | +3697.56% |
| ACIU | AC Immune SA | $232.87M | +3695.23% |
| AVXL | Anavex Life Sciences Corporation | $231.68M | +3675.84% |
| IVVD | Invivyd Inc | $231.05M | +3665.59% |
| QTTB | Q32 Bio Inc | $229.68M | +3643.30% |
| SLRN | Acelyrin Inc | $228.54M | +3624.74% |
| DTIL | Precision Biosciences Inc | $227.35M | +3605.28% |
| TARA | Protara Therapeutics Inc | $226.83M | +3596.79% |
| CGEN | Compugen Ltd | $223.15M | +3536.76% |
| CHRS | Coherus Biosciences Inc | $222.07M | +3519.28% |
| NAUT | Nautilus Biotechnology Inc | $221.10M | +3503.46% |
| CAMP | CAMP4 Therapeutics Corp | $218.61M | +3462.80% |
| KROS | Keros Therapeutics Inc | $217.65M | +3447.24% |
| ADAG | Adagene Inc | $217.38M | +3442.81% |
| SLGL | Sol-Gel Technologies Ltd | $215.10M | +3405.71% |
| KPTI | Karyopharm Therapeutics Inc | $214.84M | +3401.47% |
| OBIO | Orchestra BioMed Holdings Inc | $214.00M | +3387.74% |
| RNA | Atrium Therapeutics Inc | $210.40M | +3329.02% |
| IMUX | Immunic Inc | $205.68M | +3252.18% |
| TLSA | Tiziana Life Sciences Ltd | $201.81M | +3188.97% |
| CDXS | Codexis Inc | $200.88M | +3173.81% |
| NKTX | Nkarta Inc | $197.53M | +3119.22% |
| AGEN | Agenus Inc | $192.99M | +3045.36% |
| VYGR | Voyager Therapeutics Inc | $192.99M | +3045.35% |
| NERV | Minerva Neurosciences Inc | $189.40M | +2986.74% |
| KRRO | Korro Bio Inc | $187.93M | +2962.76% |
| PRQR | ProQR Therapeutics N.V | $186.49M | +2939.37% |
| PLX | Protalix BioTherapeutics Inc | $186.05M | +2932.15% |
| TNYA | Tenaya Therapeutics Inc | $182.97M | +2882.04% |
| MDWD | MediWound Ltd | $182.55M | +2875.21% |
| IFRX | InflaRx N.V. | $182.18M | +2869.08% |
| WHWK | Whitehawk Therapeutics Inc | $181.71M | +2861.40% |
| ARCT | Arcturus Therapeutics Holdings Inc | $181.62M | +2860.03% |
| SGMT | Sagimet Biosciences Inc - Class A | $180.81M | +2846.81% |
| ACOG | Alpha Cognition Inc | $180.73M | +2845.40% |
| MENS | Jyong Biotech Ltd | $174.10M | +2737.50% |
| ACHV | Achieve Life Sciences Inc | $173.54M | +2728.35% |
| PEPG | PepGen Inc | $168.86M | +2652.00% |
| ANTX | AN2 Therapeutics Inc | $168.05M | +2638.87% |
| CRBU | Caribou Biosciences Inc | $167.73M | +2633.54% |
| THTX | Theratechnologies Inc | $167.34M | +2627.20% |
| ALEC | Alector Inc | $166.54M | +2614.18% |
| ORMP | Oramed Pharmaceuticals Inc | $166.16M | +2608.02% |
| EQ | Equillium Inc | $165.65M | +2599.77% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $164.92M | +2587.89% |
| IPHA | Innate Pharma | $164.54M | +2581.65% |
| OTLK | Outlook Therapeutics Inc | $163.20M | +2559.75% |
| YDES | YD Bio Ltd | $160.69M | +2518.90% |
| ABOS | Acumen Pharmaceuticals Inc | $160.35M | +2513.26% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $159.83M | +2504.81% |
| LENZ | LENZ Therapeutics Inc | $156.46M | +2449.91% |
| PYXS | Pyxis Oncology Inc | $152.68M | +2388.33% |
| CNTB | Connect Biopharma Holdings Ltd | $152.39M | +2383.60% |
| HUMA | Humacyte Inc | $151.33M | +2366.30% |
| MIST | Milestone Pharmaceuticals Inc | $149.60M | +2338.12% |
| NBP | NovaBridge Biosciences. | $149.30M | +2333.21% |
| NRXP | NRX Pharmaceuticals Inc | $149.28M | +2332.95% |
| AKTX | Akari Therapeutics Plc | $148.12M | +2314.09% |
| MOLN | Molecular Partners AG | $146.63M | +2289.81% |
| ARMP | Armata Pharmaceuticals Inc | $146.49M | +2287.39% |
| AARD | Aardvark Therapeutics Inc | $145.52M | +2271.56% |
| MRSN | Mersana Therapeutics Inc | $145.36M | +2268.97% |
| HURA | TuHURA Biosciences Inc | $144.96M | +2262.50% |
| GUTS | Fractyl Health Inc | $144.37M | +2252.91% |
| PROK | ProKidney Corp - Class A | $137.85M | +2146.64% |
| TCRX | Tscan Therapeutics Inc | $137.63M | +2142.99% |
| CBUS | Cibus Global Ltd. Class A | $135.62M | +2110.30% |
| THAR | Tharimmune Inc | $135.41M | +2106.85% |
| SEER | Seer Inc - Class A | $132.16M | +2053.94% |
| GNLX | Genelux Corp | $130.49M | +2026.61% |
| VXRT | Vaxart Inc | $127.95M | +1985.28% |
| ENGN | enGene Holdings Inc | $127.28M | +1974.37% |
| UNCY | Unicycive Therapeutics Inc | $126.69M | +1964.81% |
| PMN | ProMIS Neurosciences Inc | $125.59M | +1946.87% |
| FBIO | Fortress Biotech Inc | $123.12M | +1906.61% |
| RANI | Rani Therapeutics Holdings Inc Class A | $121.86M | +1885.99% |
| VANI | Vivani Medical Inc | $119.35M | +1845.19% |
| ANIX | Anixa Biosciences Inc | $118.73M | +1835.02% |
| ALDX | Aldeyra Therapeutics Inc | $115.82M | +1787.54% |
| SAVA | Cassava Sciences Inc. | $114.97M | +1773.79% |
| RPTX | Repare Therapeutics Inc | $113.91M | +1756.51% |
| COYA | Coya Therapeutics Inc | $113.53M | +1750.32% |
| KLRS | Kalaris Therapeutics Inc | $110.82M | +1706.16% |
| ONCY | Oncolytics Biotech Inc | $104.98M | +1610.93% |
| HLVX | HilleVax Inc | $104.74M | +1607.00% |
| BDTX | Black Diamond Therapeutics Inc | $103.72M | +1590.33% |
| ADVM | Adverum Biotechnologies Inc | $102.40M | +1568.94% |
| SPRO | Spero Therapeutics Inc | $98.42M | +1503.95% |
| KZIA | Kazia Therapeutics Ltd | $97.74M | +1492.94% |
| VRCA | Verrica Pharmaceuticals Inc | $97.23M | +1484.66% |
| ICCC | Immucell Corp | $97.07M | +1482.05% |
| BMEA | Biomea Fusion Inc | $93.27M | +1420.02% |
| CUE | Cue Biopharma Inc | $92.75M | +1411.53% |
| ENLV | Enlivex Ltd | $92.47M | +1406.99% |
| PTHS | Channel Therapeutics Corporation | $91.66M | +1393.87% |
| MAIA | MAIA Biotechnology Inc | $89.19M | +1353.54% |
| NTHI | NeOnc Technologies Holdings Inc | $87.88M | +1332.26% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $86.99M | +1317.74% |
| CRDF | Cardiff Oncology Inc | $85.46M | +1292.84% |
| RLYB | Rallybio Corp | $85.33M | +1290.71% |
| CGTX | Cognition Therapeutics Inc | $84.81M | +1282.14% |
| LPTX | Leap Therapeutics Inc | $84.76M | +1281.37% |
| ATHE | Alterity Therapeutics Ltd | $84.66M | +1279.78% |
| ACET | Adicet Bio Inc | $83.31M | +1257.73% |
| HRTX | Heron Therapeutics Inc | $83.25M | +1256.86% |
| ENTX | Entera Bio Ltd | $82.99M | +1252.51% |
| INO | Inovio Pharmaceuticals Inc | $81.63M | +1230.46% |
| CSBR | Champions Oncology Inc | $80.27M | +1208.15% |
| NRXS | Neuraxis Inc | $79.92M | +1202.53% |
| FBIOP | Fortress Biotech Inc | $77.72M | +1166.66% |
| ATHA | Athira Pharma Inc | $77.21M | +1158.42% |
| PMVP | PMV Pharmaceuticals Inc | $74.66M | +1116.86% |
| GLTO | Galecto Inc | $74.66M | +1116.71% |
| ACRV | Acrivon Therapeutics Inc | $74.39M | +1112.39% |
| ATRA | Atara Biotherapeutics Inc | $72.78M | +1086.11% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $71.93M | +1072.23% |
| GANX | Gain Therapeutics Inc | $71.38M | +1063.34% |
| XBIT | XBiotech Inc | $69.82M | +1037.85% |
| PLRX | Pliant Therapeutics Inc | $69.34M | +1030.15% |
| HYFT | MindWalk Holdings Corp | $69.31M | +1029.57% |
| MNOV | Medicinova Inc | $68.91M | +1023.07% |
| SPRB | Spruce Biosciences Inc | $67.96M | +1007.51% |
| IMA | Ikena Oncology Inc | $67.49M | +999.96% |
| ELTX | Elicio Therapeutics Inc | $65.05M | +960.22% |
| IMMP | Immutep Ltd | $64.23M | +946.81% |
| KLTO | Klotho Neurosciences Inc Com | $63.55M | +935.77% |
| ACHL | Achilles Therapeutics Plc | $63.22M | +930.34% |
| EDSA | Edesa Biotech Inc | $61.04M | +894.89% |
| OSTX | OS Therapies Inc | $60.88M | +892.22% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $59.20M | +864.82% |
| IBIO | iBio Inc | $58.38M | +851.44% |
| CNTX | Context Therapeutics Inc | $57.91M | +843.82% |
| OKYO | OKYO Pharma Ltd - New | $56.13M | +814.82% |
| BOLD | Boundless Bio Inc | $55.35M | +802.00% |
| INMB | INmune Bio Inc | $55.03M | +796.89% |
| CING | Cingulate Inc | $54.66M | +790.82% |
| KZR | Kezar Life Sciences Inc | $53.76M | +776.15% |
| INKT | MiNK Therapeutics Inc | $53.21M | +767.17% |
| XLO | Xilio Therapeutics Inc | $52.74M | +759.49% |
| MREO | Mereo Biopharma Group Plc | $52.58M | +756.97% |
| ATYR | Atyr Pharma Inc | $52.39M | +753.82% |
| MCRB | Seres Therapeutics Inc | $52.28M | +752.01% |
| BYSI | BeyondSpring Inc | $52.22M | +751.10% |
| EXOZ | Invizyne Technologies Inc | $51.89M | +745.71% |
| RNTX | Rein Therapeutics Inc | $51.79M | +744.13% |
| TIL | Instil Bio Inc | $51.68M | +742.24% |
| ANVS | Annovis Bio Inc | $51.65M | +741.82% |
| GOSS | Gossamer Bio Inc | $51.14M | +733.47% |
| IBO | Impact BioMedical Inc | $50.13M | +716.94% |
| MGX | Metagenomi Inc | $48.56M | +691.49% |
| DWTX | Virios Therapeutics Inc | $48.10M | +683.89% |
| LVTX | LAVA Therapeutics NV | $45.77M | +645.97% |
| TELO | Telomir Pharmaceuticals Inc | $45.73M | +645.24% |
| DYAI | Dyadic International Inc DE | $44.46M | +624.52% |
| PDSB | PDS Biotechnology Corporation | $41.64M | +578.61% |
| APLM | Apollomics Inc - Class A | $41.33M | +573.61% |
| ACTU | Actuate Therapeutics Inc | $40.78M | +564.69% |
| FGEN | FibroGen Inc | $39.31M | +540.60% |
| GRCE | Acasti Pharma Inc | $38.94M | +534.61% |
| VERU | Veru Inc | $38.84M | +533.03% |
| RNXT | RenovoRx Inc | $38.73M | +531.17% |
| NNVC | NanoViricides Inc | $37.23M | +506.80% |
| NTRB | Nutriband Inc | $37.08M | +504.25% |
| RADX | Radiopharm Theranostics Ltd | $36.10M | +488.43% |
| GBIO | Generation Bio Company | $35.97M | +486.20% |
| GNTA | Genenta Science SpA | $35.85M | +484.29% |
| ALGS | Aligos Therapeutics Inc | $35.71M | +481.92% |
| MURA | Mural Oncology plc | $35.34M | +476.00% |
| LTRN | Lantern Pharma Inc | $34.89M | +468.62% |
| LITS | Lite Strategy Inc | $34.77M | +466.72% |
| HYPD | Eyenovia Inc | $34.51M | +462.50% |
| LSTA | Lisata Therapeutics Inc | $34.15M | +456.60% |
| ABVC | ABVC BioPharma Inc | $32.98M | +437.54% |
| ESLA | Estrella Immunopharma Inc | $32.50M | +429.75% |
| SNTI | Senti Biosciences Inc | $32.39M | +427.89% |
| DARE | Dare Bioscience Inc | $30.14M | +391.18% |
| SER | AgeX Therapeutics Inc | $29.05M | +373.50% |
| SGMO | Sangamo Therapeutics Inc | $28.83M | +369.89% |
| BCTX | BriaCell Therapeutics Corp - New | $28.57M | +365.57% |
| ATNM | Actinium Pharmaceuticals Inc | $28.56M | +365.47% |
| CRVO | CervoMed Inc | $28.42M | +363.25% |
| PSTV | Plus Therapeutics Inc | $28.00M | +356.29% |
| TVRD | Cara Therapeutics Inc | $27.49M | +347.98% |
| BRNS | Barinthus Biotherapeutics Plc. | $26.44M | +330.87% |
| IGC | IGC Pharma Inc | $26.36M | +329.59% |
| EVAX | Evaxion Biotech A/S | $25.44M | +314.58% |
| VYNE | VYNE Therapeutics Inc | $25.25M | +311.59% |
| GRDX | Entero Therapeutics Inc | $24.74M | +303.18% |
| NXTC | Nextcure Inc | $23.92M | +289.81% |
| MRKR | Marker Therapeutics Inc | $23.55M | +283.76% |
| NRSN | NeuroSense Therapeutics Ltd | $23.41M | +281.45% |
| CELU | Celularity Inc - Class A | $22.49M | +266.59% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $21.96M | +257.83% |
| OPT | Opthea Ltd | $21.53M | +250.88% |
| SKYE | Skye Bioscience Inc | $21.29M | +246.98% |
| PLRZ | Polyrizon Ltd | $21.02M | +242.58% |
| ATOS | Atossa Therapeutics Inc | $21.01M | +242.44% |
| PHXM | PHAXIAM Therapeutics SA ADR | $20.38M | +232.09% |
| TVGN | Tevogen Bio Holdings Inc | $19.93M | +224.75% |
| SNSE | Sensei Biotherapeutics Inc | $19.48M | +217.40% |
| JSPR | Jasper Therapeutics Inc | $19.37M | +215.75% |
| KALA | Kala Bio Inc | $19.15M | +212.06% |
| NEUP | Neuphoria Therapeutics Inc | $18.93M | +208.49% |
| NCEL | NLS Pharmaceutics Ltd | $18.85M | +207.28% |
| ALLR | Allarity Therapeutics Inc | $18.67M | +204.22% |
| ICU | SeaStar Medical Holding Corp | $18.45M | +200.71% |
| PLUR | Pluri Inc | $18.25M | +197.50% |
| LPCN | Lipocine Inc | $17.64M | +187.51% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $17.55M | +186.09% |
| HOWL | Werewolf Therapeutics Inc | $16.50M | +168.89% |
| HIND | ReShape Lifesciences Inc | $15.93M | +159.66% |
| PTN | Palatin Technologies Inc | $15.81M | +157.65% |
| PASG | Passage Bio Inc | $15.75M | +156.69% |
| LGVN | Longeveron Inc - Class A | $15.75M | +156.64% |
| CYCN | Cyclerion Therapeutics Inc | $15.74M | +156.45% |
| TPST | Tempest Therapeutics Inc | $15.35M | +150.14% |
| CLRB | Cellectar Biosciences Inc | $14.97M | +143.94% |
| APLT | Applied Therapeutics Inc | $14.86M | +142.23% |
| HOTH | Hoth Therapeutics Inc | $14.64M | +138.65% |
| LEXX | Lexaria Bioscience Corp | $14.58M | +137.58% |
| IOBT | IO Biotech Inc | $14.50M | +136.29% |
| HOOK | Hookipa Pharma Inc | $14.43M | +135.12% |
| INAB | IN8bio Inc | $14.18M | +131.10% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $14.00M | +128.15% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $13.82M | +125.25% |
| BIVI | BioVie Inc - Class A | $13.35M | +117.56% |
| BLRX | Bioline Rx Ltd | $13.35M | +117.50% |
| LNAI | Lunai Bioworks Inc | $13.33M | +117.17% |
| COCP | Cocrystal Pharma Inc | $13.24M | +115.71% |
| QNCX | Quince Therapeutics Inc | $13.03M | +112.42% |
| LSB | LakeShore Biopharma Co Ltd | $13.02M | +112.21% |
| GTBP | GT Biopharma Inc | $12.33M | +100.91% |
| MBRX | Moleculin Biotech Inc | $12.33M | +100.90% |
| CALC | CalciMedica Inc | $12.31M | +100.56% |
| INTS | Intensity Therapeutics Inc | $12.30M | +100.40% |
| AIM | AIM ImmunoTech Inc. | $12.01M | +95.74% |
| KTTA | Pasithea Therapeutics Corp | $11.92M | +94.29% |
| QNRX | Quoin Pharmaceuticals Ltd | $11.92M | +94.24% |
| CTXR | Citius Pharmaceuticals Inc | $11.88M | +93.68% |
| GDTC | CytoMed Therapeutics Ltd | $11.32M | +84.50% |
| TOVX | Theriva Biologics Inc | $11.15M | +81.68% |
| CMMB | Chemomab Therapeutics Ltd | $10.93M | +78.17% |
| BCLI | Brainstorm Cell Therapeutics Inc | $10.73M | +74.93% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $10.43M | +69.93% |
| PHIO | Phio Pharmaceuticals Corp | $10.34M | +68.53% |
| XCUR | Exicure Inc | $10.33M | +68.29% |
| CVM | Cel-Sci Corp | $10.15M | +65.35% |
| MLEC | Moolec Science SA | $10.06M | +63.91% |
| KPRX | Kiora Pharmaceuticals Inc | $9.90M | +61.41% |
| BCDA | BioCardia Inc | $9.59M | +56.23% |
| MTVA | MetaVia Inc | $9.55M | +55.71% |
| VTGN | VistaGen Therapeutics Inc | $9.48M | +54.45% |
| CRIS | Curis Inc | $9.45M | +54.09% |
| TRAW | Traws Pharma Inc | $9.16M | +49.31% |
| ASBP | Aspire Biopharma Holdings Inc | $9.03M | +47.16% |
| EPIX | Essa Pharma Inc | $8.93M | +45.55% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $8.92M | +45.33% |
| IMNN | Imunon Inc | $8.71M | +41.90% |
| BRTX | BioRestorative Therapies Inc | $8.66M | +41.18% |
| APRE | Aprea Therapeutics Inc | $8.48M | +38.19% |
| ADXN | Addex Therapeutics Ltd | $8.21M | +33.73% |
| SYBX | Synlogic Inc | $8.20M | +33.69% |
| IMRN | Immuron Ltd | $8.15M | +32.86% |
| BOLT | Bolt Biotherapeutics Inc | $8.09M | +31.85% |
| ITRM | Iterum Therapeutics Plc | $8.06M | +31.38% |
| RNAZ | TransCode Therapeutics Inc | $7.97M | +29.94% |
| ERNA | Ernexa Therapeutics Inc | $7.85M | +27.89% |
| PMCB | PharmaCyte Biotech Inc | $7.57M | +23.42% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $7.49M | +21.99% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | $7.34M | +19.56% |
| AEON | AEON Biopharma Inc - Class A | $7.31M | +19.14% |
| BCAB | BioAtla Inc | $7.07M | +15.22% |
| CANF | Can-Fite Biopharma Ltd | $6.87M | +12.04% |
| KAPA | Kairos Pharma Ltd | $6.75M | +9.99% |
| XBIO | Xenetic Biosciences Inc | $6.65M | +8.41% |
| JUNS | Jupiter Neurosciences Inc | $6.48M | +5.55% |
| PCSA | Processa Pharmaceuticals Inc | $6.40M | +4.31% |
| GOVX | Geovax Labs Inc | $6.29M | +2.44% |
| CURX | Curanex Pharmaceuticals Inc | $6.11M | -0.47% |
| PPBT | Purple Biotech Ltd | $6.05M | -1.41% |
| HCWB | HCW Biologics Inc | $6.02M | -1.84% |
| APM | Aptorum Group Limited Class A Ordinary Shares | $6.01M | -2.00% |
| ACXP | Acurx Pharmaceuticals Inc | $5.93M | -3.34% |
| CVKD | Cadrenal Therapeutics Inc | $5.89M | -3.99% |
| EVGN | Evogene Ltd | $5.64M | -8.03% |
| APVO | Aptevo Therapeutics Inc | $5.50M | -10.34% |
| CDIO | Cardio Diagnostics Holdings Inc | $5.30M | -13.66% |
| SILO | SILO Pharma Inc | $5.29M | -13.80% |
| DRMA | Dermata Therapeutics Inc | $5.23M | -14.78% |
| LIMN | Liminatus Pharma Inc | $5.14M | -16.25% |
| TCRT | Alaunos Therapeutics Inc | $5.07M | -17.44% |
| BGMS | Bio Green Med Solution Inc | $5.00M | -18.56% |
| NCNA | NuCana plc | $4.99M | -18.66% |
| TTNP | Titan Pharmaceuticals Inc (de) | $4.91M | -19.98% |
| CLGN | CollPlant Biotechnologies Ltd New | $4.80M | -21.83% |
| ALZN | Alzamend Neuro Inc | $4.68M | -23.73% |
| GNPX | Genprex Inc | $4.44M | -27.64% |
| CASI | CASI Pharmaceuticals Inc | $4.27M | -30.48% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $4.26M | -30.51% |
| REVB | Revelation Biosciences Inc | $4.26M | -30.57% |
| MBIO | Mustang Bio Inc | $4.25M | -30.68% |
| ADIL | Adial Pharmaceuticals Inc | $4.24M | -30.88% |
| ENVB | Enveric Biosciences Inc | $4.15M | -32.32% |
| CNSP | Cns Pharmaceuticals Inc | $4.14M | -32.55% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $4.09M | -33.39% |
| SNGX | Soligenix Inc | $3.91M | -36.23% |
| PBM | Psyence Biomedical Ltd | $3.76M | -38.67% |
| CELZ | Creative Medical Technology Holdings Inc | $3.70M | -39.75% |
| GLMD | Galmed Pharmaceuticals Ltd | $3.38M | -44.92% |
| XRTX | XORTX Therapeutics Inc | $3.34M | -45.54% |
| FBLG | FibroBiologics Inc | $3.18M | -48.18% |
| SLXN | Silexion Therapeutics Corp | $3.11M | -49.31% |
| SPRC | SciSparc Ltd | $3.05M | -50.36% |
| BDRX | Biodexa Pharmaceuticals Plc | $2.98M | -51.40% |
| AFMD | Affimed N.V. | $2.98M | -51.51% |
| ENSC | Ensysce Biosciences Inc | $2.88M | -53.13% |
| ARTL | Artelo Biosciences Inc | $2.75M | -55.24% |
| GRI | GRI Bio Inc | $2.57M | -58.15% |
| ONCO | Onconetix Inc | $2.54M | -58.62% |
| PPCB | Propanc Biopharma Inc | $2.50M | -59.23% |
| VIVS | VivoSim Labs Inc | $2.47M | -59.77% |
| OGEN | Oragenics Inc | $2.45M | -60.06% |
| NBY | Stablecoin Development Corp | $2.40M | -60.81% |
| NTBL | Notable Labs Inc Ord | $2.39M | -60.97% |
| BBLG | Bone Biologics Corp | $2.23M | -63.72% |
| AZTR | Azitra Inc | $2.22M | -63.77% |
| MTNB | Matinas Biopharma Holdings Inc | $2.18M | -64.43% |
| CLSD | Clearside Biomedical, Inc. Common Stock | $2.15M | -65.03% |
| CMND | Clearmind Medicine Inc | $2.12M | -65.53% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $2.09M | -65.97% |
| CLDI | Calidi Biotherapeutics Inc | $1.99M | -67.50% |
| ONCT | Oncternal Therapeutics Inc | $1.56M | -74.60% |
| VRAX | Virax Biolabs Group Ltd - Class A | $1.52M | -75.24% |
| ABP | Abpro Holdings, Inc Common Stock | $1.43M | -76.75% |
| JAGX | Jaguar Health Inc | $1.34M | -78.10% |
| ZVSA | ZyVersa Therapeutics Inc | $1.03M | -83.22% |
| LYRA | Lyra Therapeutics Inc | $927198.36 | -84.89% |
| SCNI | Scinai Immunotherapeutics Ltd | $912143.15 | -85.13% |
| TNFA | TNF Pharmaceuticals Inc | $551031.39 | -91.02% |
| SLRX | Decoy Therapeutics Inc | $446853.12 | -92.72% |
| ELAB | PMGC Holdings Inc | $221376.00 | -96.39% |
| CDT | CDT Equity Inc | $110551.31 | -98.20% |
| ADTX | Aditxt Inc | $98471.97 | -98.40% |